| Inhibition of telomerase activity by geldanamycin and 17-allylamino, 17-demethoxygeldanamycin in human melanoma cells. | |
| | |
MedLine Citation:
|
PMID: 12771028 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
As it has been demonstrated that the heat shock protein 90 (HSP90) is required for the assembly and activation of telomerase in human cells, we investigated the effect exerted by the ansamycin antibiotics geldanamycin (GA) and 17-allylamino,17-demethoxygeldanamycin (17-AAG), two well-known inhibitors of the HSP90 chaperone function, on telomerase activity in JR8 human melanoma cells. Using an antibody to HSP90, we precipitated the telomerase activity associated with the molecular chaperone. The results of TRAP (telomeric repeat amplification protocol) experiments carried out on HSP90 immunoprecipitates showed that exposure to 100 ng/ml GA and 17-AAG induced a significant (P < 0.01) inhibition of telomerase activity, which was observed at earlier time points than drug-induced inhibition of cell proliferation. Superimposable results were obtained from TRAP experiments carried out on total JR8 protein extracts. To investigate whether the basal level of telomerase activity of the tumour cell system plays a role in determining the cellular response to 17-AAG, we compared the cytotoxic activity of the drug in JR8 cells and in two JR8-derived clones that were stably transfected with a hammerhead ribozyme targeting the RNA template of telomerase and were characterized by a markedly lower telomerase activity than the parental cells. The cytotoxicity results indicated that both ribozyme-transfectant clones were almost 2-fold more sensitive to 72 h 17-AAG exposure than JR8 cells as a consequence of a more than double apoptotic response [in terms of the percentage of apoptotic nuclei in cells stained with propidium iodide and the percentage of Tdt-mediated dUTP nick-end labelling (TUNEL)-positive cells]. In summary, our results suggest that (i) telomerase is a target of GA and 17-AAG action and its inhibition may contribute to the cytotoxic activity of the drugs, (ii) the basal level of telomerase activity of the tumour cell system may also have a role in influencing 17-AAG cytotoxicity. |
| | |
Authors:
|
Raffaella Villa; Marco Folini; Chiara Della Porta; Alessandra Valentini; Marzia Pennati; Maria Grazia Daidone; Nadia Zaffaroni |
Related Documents
:
|
21717308 - Functional molecular morphology of anterior pituitary cells, from hormone production to... 10089218 - Influence of skeletal site of origin and donor age on osteoblastic cell growth and diff... 10411308 - Loss of several cell functions including okadaic acid-induced apoptosis after multiple ... 16810748 - Inhibitory effects of antisense phosphorothioate oligodeoxynucleotides on pancreatic ca... 3491868 - Cell growth cycle block of t cell hybridomas upon activation with antigen. 22264088 - Growth, bioconversion of isoflavones and probiotic properties of parent and subsequent ... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Carcinogenesis Volume: 24 ISSN: 0143-3334 ISO Abbreviation: Carcinogenesis Publication Date: 2003 May |
Date Detail:
|
Created Date: 2003-05-28 Completed Date: 2003-07-10 Revised Date: 2009-11-19 |
Medline Journal Info:
|
Nlm Unique ID: 8008055 Medline TA: Carcinogenesis Country: England |
Other Details:
|
Languages: eng Pagination: 851-9 Citation Subset: IM |
Affiliation:
|
Department of Experimental Oncology, Unit 10, Istituto Nazionale per lo Studio e la Cura dei Tumori, Via Venezian 1, 20133 Milan, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Apoptosis
/
drug effects Benzoquinones Cell Cycle / drug effects Cell Division / drug effects DNA Primers / chemistry Dose-Response Relationship, Drug Enzyme Inhibitors / pharmacology* Flow Cytometry HSP90 Heat-Shock Proteins / metabolism* Humans In Situ Nick-End Labeling Lactams, Macrocyclic Melanoma / enzymology*, pathology Polymerase Chain Reaction Precipitin Tests Protein-Tyrosine Kinases / antagonists & inhibitors Quinones / pharmacology* Rifabutin / analogs & derivatives*, pharmacology* Telomerase / antagonists & inhibitors* Telomere / metabolism Tumor Cells, Cultured / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/17-(allylamino)-17-demethoxygeldanamycin; 0/Benzoquinones; 0/DNA Primers; 0/Enzyme Inhibitors; 0/HSP90 Heat-Shock Proteins; 0/Lactams, Macrocyclic; 0/Quinones; 30562-34-6/geldanamycin; 72559-06-9/Rifabutin; EC 2.7.10.1/Protein-Tyrosine Kinases; EC 2.7.7.49/Telomerase |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: p53 responsive nucleotide excision repair gene products p48 and XPC, but not p53, localize to sites ...
Next Document: Global expression analysis of N-methyl-N'-nitro-N-nitrosoguanidine-induced rat stomach carcinomas us...